Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got another busy week of earnings — Pfizer reported this morning and Novo Nordisk will be reporting tomorrow. We’ll be watching for any discussion on the Metsera bidding war.
We’re also continuing to track the fallout from all the recent FDA controversies.
Continue to STAT+ to read the full story…
STAT Pharma: The science and business of new drug development
Leave a Reply